IntroductionThis databook is a detailed information resource covering all the key data points on Soft drinks in Thailand. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2008 and full forecasts to 2013.Scope*Contains information on 7 categories: Carbonates, Bottled water, Juices, RTD tea & coffee, Functional drinks, Smoothies and Concentrates*Provides market value, volume, expenditure and consumption data by market, category and segment*Includes company and brand share data by categoriesHighlightsThe market for Soft drinks in Thailand increased between 2003-2008, growing at an average annual rate of 4.6%.The leading company in the market in 2008 was Pepsico, Inc. The second-largest player was Coca-Cola Company, The with Nestle S.A. in third place.Reasons to Purchase*Discover the major quantitative trends affecting the Soft drinks markets*Understand consumers' consumption and expenditure patterns*Understand the future direction of the market with reliable historical data and full five year forecasting
Smartphones: When is the first and last time you check yours?ReportLinker.com
Nearly half (46%) of Americans say they check their smartphones as soon as they wake up, while they’re still in bed, according to ReportLinker’s survey results. This is especially true of Millennials, 66% of whom say it’s the first thing they do before getting out of bed.
75% of Ameircans say they keep their smartphones active all day and night, and a staggering 83% of Millennials say they do.
In fact, disconnecting can be hard. More than half of Americans say their last check is right before bed – and 13% say they disconnect only after they’ve gotten into bed for the night. Even after they fall asleep, about 10% say they’ll wake up and check it during the night.
This graphic shows Samsung's customers are still loyal: 86% of Samsung Customers would consider Samsung next time they upgrade their smartphone. More info on reportlinker.com/inisght
Allegra Strategies is proud to release the 2012 report on European branded coffee shop market, providing comprehensive research on this fast developing market.The ProjectCaf
Allegra's definitive annual study on the UK branded coffee shop market is now available; with insight from over 25,000 consumers the report provides an authoritative view of the market.Drawing on more than 12 years in-depth research, it is considered to be the bible of the coffee sector.KEY AREAS COVERED' Market size and growth projections for the total UK market' Impact of recent economic downturn on trading performance' Key player profiles, including financial performance, pricing analysis and forecasts' Importance of ethical and sustainability issues' Key success factors and market trends' Opportunities and challenges for suppliers' Consumer coffee consumption patterns' Consumer brand awareness and perceptions of key players' Differences between customer demographics, including age, gender, occupation and location by the reportSOURCE OF INFORMATION' Interviews with CEOs, managing directors, senior managers and store managers of major industry players, including:' leading UK coffee and food-focused chains' major coffee roasters and key equipment suppliers' non-specialist players including department stores, supermarkets, bookstores' leading property companies, letting agents and landlords' local authorities' Online surveys with UK coffee shop visitors' Desk research including: News articles and trade press, the Internet and company websites,industry associations, published accounts, data supplied by operators' In-store observations and analysis
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...ReportLinker.com
WinterGreen Research announces that it has published a new study Wireless Infrastructure: Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2019. Next generation mission critical systems are leveraging new technology. The 2013 study has 554 pages, 245 tables and figures. Worldwide Wireless Infrastructure markets are poised to achieve significant growth as Building out core networks and backhaul for smart phones.A smart phone is not very smart if the infrastructure can't support its applications. In response to the high growth smart phone markets, wireless infrastructure promises to grow dramatically in the near term.. Wireless Infrastructure technologies include WiMax, LTE, 4G and HSPA. These technologies are driving much higher capacity from the base station back to the fiber core. Fiber core is putting extreme pressure on provider's infrastructure and backhaul networks.WinterGreen Research predicts that the dramatic growth of wireless infrastructure is based on the growth of smart phones to a one trillion market by 2019, serving an installed base of 8.5 billion, many people having more than one smart phone. Wireless infrastructure markets at $58 billion in 2012 will be $163 billion by 2019, new markets evolved because of the value that apps provide to smart phones, mobile devices, tablets, and the Internet of things.According to Susan Eustis, lead author of the study, 'Wireless Infrastructure is being installed to upgrade core networks and upgrade backhaul and base stations to make systems more modern. Infrastructure for the Internet and for smart mobile devices creates demand for more sophisticated web development and web applications that in turn depend on more sophisticated infrastructure. Everything is going mobile. This evolution is driven by mobile smart phones and tablets that provide universal connectivity. Modern systems represent a significant aspect of Internet market evolution.'The proportions of wireless infrastructure market industry segments are expected to remain much as they are, with the small cells and femtocells achieving strong growth on the access side, the core infrastructure must be upgraded to support the added backhaul backbone infrastructure. Wireless apps are expected to achieve $37 trillion revenue by 2019. This unbelievable growth occurs as the Internet is expanded to implement the interconnection of everything.Digital devices proliferate, machine to machine capabilities vastly expand instrumentation. The digital devices become the engine of a world economy, with apps collecting pennies a day for millions of apps from 8.5 billion people with smart phones by 2019.
Smartphones: When is the first and last time you check yours?ReportLinker.com
Nearly half (46%) of Americans say they check their smartphones as soon as they wake up, while they’re still in bed, according to ReportLinker’s survey results. This is especially true of Millennials, 66% of whom say it’s the first thing they do before getting out of bed.
75% of Ameircans say they keep their smartphones active all day and night, and a staggering 83% of Millennials say they do.
In fact, disconnecting can be hard. More than half of Americans say their last check is right before bed – and 13% say they disconnect only after they’ve gotten into bed for the night. Even after they fall asleep, about 10% say they’ll wake up and check it during the night.
This graphic shows Samsung's customers are still loyal: 86% of Samsung Customers would consider Samsung next time they upgrade their smartphone. More info on reportlinker.com/inisght
Allegra Strategies is proud to release the 2012 report on European branded coffee shop market, providing comprehensive research on this fast developing market.The ProjectCaf
Allegra's definitive annual study on the UK branded coffee shop market is now available; with insight from over 25,000 consumers the report provides an authoritative view of the market.Drawing on more than 12 years in-depth research, it is considered to be the bible of the coffee sector.KEY AREAS COVERED' Market size and growth projections for the total UK market' Impact of recent economic downturn on trading performance' Key player profiles, including financial performance, pricing analysis and forecasts' Importance of ethical and sustainability issues' Key success factors and market trends' Opportunities and challenges for suppliers' Consumer coffee consumption patterns' Consumer brand awareness and perceptions of key players' Differences between customer demographics, including age, gender, occupation and location by the reportSOURCE OF INFORMATION' Interviews with CEOs, managing directors, senior managers and store managers of major industry players, including:' leading UK coffee and food-focused chains' major coffee roasters and key equipment suppliers' non-specialist players including department stores, supermarkets, bookstores' leading property companies, letting agents and landlords' local authorities' Online surveys with UK coffee shop visitors' Desk research including: News articles and trade press, the Internet and company websites,industry associations, published accounts, data supplied by operators' In-store observations and analysis
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...ReportLinker.com
WinterGreen Research announces that it has published a new study Wireless Infrastructure: Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2019. Next generation mission critical systems are leveraging new technology. The 2013 study has 554 pages, 245 tables and figures. Worldwide Wireless Infrastructure markets are poised to achieve significant growth as Building out core networks and backhaul for smart phones.A smart phone is not very smart if the infrastructure can't support its applications. In response to the high growth smart phone markets, wireless infrastructure promises to grow dramatically in the near term.. Wireless Infrastructure technologies include WiMax, LTE, 4G and HSPA. These technologies are driving much higher capacity from the base station back to the fiber core. Fiber core is putting extreme pressure on provider's infrastructure and backhaul networks.WinterGreen Research predicts that the dramatic growth of wireless infrastructure is based on the growth of smart phones to a one trillion market by 2019, serving an installed base of 8.5 billion, many people having more than one smart phone. Wireless infrastructure markets at $58 billion in 2012 will be $163 billion by 2019, new markets evolved because of the value that apps provide to smart phones, mobile devices, tablets, and the Internet of things.According to Susan Eustis, lead author of the study, 'Wireless Infrastructure is being installed to upgrade core networks and upgrade backhaul and base stations to make systems more modern. Infrastructure for the Internet and for smart mobile devices creates demand for more sophisticated web development and web applications that in turn depend on more sophisticated infrastructure. Everything is going mobile. This evolution is driven by mobile smart phones and tablets that provide universal connectivity. Modern systems represent a significant aspect of Internet market evolution.'The proportions of wireless infrastructure market industry segments are expected to remain much as they are, with the small cells and femtocells achieving strong growth on the access side, the core infrastructure must be upgraded to support the added backhaul backbone infrastructure. Wireless apps are expected to achieve $37 trillion revenue by 2019. This unbelievable growth occurs as the Internet is expanded to implement the interconnection of everything.Digital devices proliferate, machine to machine capabilities vastly expand instrumentation. The digital devices become the engine of a world economy, with apps collecting pennies a day for millions of apps from 8.5 billion people with smart phones by 2019.
Global Electric Resistance Welded Pipes IndustryReportLinker.com
This report analyzes the worldwide markets for Electric Resistance Welded Pipes in Thousand Tons by the following Product Segments: Mechanical Steel Tubing, Structural Tubing, Structural Steel Pipes, Pressure Tubing, Standard Pipes, Oil Country Tubular Goods, and Line Pipes. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 181 companies including many key and niche players such as Al Jazeera Steel Products Company SAOG, Arabian Pipes Company, ArcelorMittal SA, ERW Pipes Portfolio of ArcelorMittal ChelPipe, Choo Bee Metal Industries Berhad, EVRAZ North America, JFE Steel Corporation, Maharashtra Seamless Limited, Melewar Industrial Group Berhad, Nippon Steel & Sumitomo Metal Corporation, Northwest Pipe Company, OAO TMK, TMK IPSCO, PT Bakrie Pipe Industries, Salzgitter Mannesmann Line Pipe GmbH, Tata Steel Europe, Techint Group SpA, Tenaris S.A., TenarisSiderca, Ternium S.A., United States Steel Corporation, United Metallurgical Company /OMK, Welspun Corp Ltd., Wheatland Tube Company, and Select Products of Wheatland Tube Company. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
This report analyzes the worldwide markets for Wireless Gaming in US$ Million by the following Product Segments: Messaging Based Wireless Gaming, Browser/Web Based Wireless Gaming, and Downloadable Wireless Gaming. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. The report profiles 90 companies including many key and niche players such as Blockdot, Inc., DeNA Co., Ltd., Electronic Arts, Inc., Gameloft SA,GAMEVIL, GREE International, Inc., Glu Mobile Inc., GigaMedia Limited, HandyGames, I-play, Itsmy
Hyperalgesia Global Clinical Trials Review, H1, 2013ReportLinker.com
Hyperalgesia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Hyperalgesia Global Clinical Trials Review, H1, 2013" provides data on the Hyperalgesia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperalgesia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hyperalgesia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Genital Herpes Global Clinical Trials Review, H1, 2013ReportLinker.com
Genital Herpes Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Genital Herpes Global Clinical Trials Review, H1, 2013" provides data on the Genital Herpes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Genital Herpes. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Genital Herpes. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
The Future of Direct Communications Technologies and Proximity-based Applicat...ReportLinker.com
Overview: There are a number of technologies that may be deployed that all provide the ability for devices to "discover" one another, although over different distances ranging from centimeters (Near Field Communications), to meters (Bluetooth), to 10s of meters (Wi-Fi). They also all provide the ability for the devices to communicate directly with one another without a centralized network. Some of these use direct communication as their primary mode of communication e.g. NFC or RFID. Others are more traditional networks which provide direct communication ability as an adjunct to their primary network functions e.g. LTE-Direct or Wi-Fi Direct. Most of the short-term drivers for proximity-based services will be mobile advertising and social networking, especially friend-finder services or dating services, and gaming. In the longer term, other applications will come into play within the scope of the so called Internet of Things. The challenge and opportunity for network operators will be to develop new user scenarios and even new business models to generate revenues from these services. This research uncovers opportunities that will be both beneficial and disruptive to the existing ecosystem and value chain. This research is must reading for any company that is considering offerings within proximity and direct communications and any company that wants to stay ahead of the crowd in terms of preparation for these disruptive technologies. Target Audience: ' Mobile network operators' Industry verticals of all types' Wireless device manufacturers' Network infrastructure companies' Advertising agencies, brands, and merchants' Social networks, advertising, and content providers' Proximity, location, and direct communications vendors Key Report Benefits: ' Market forecasts for each significant technology/solution approach' Recognize the upcoming role and importance of LTE Direct compared to other solutions' Analysis of the major vendors focused on proximity and direct communications solutions' Understand the relationship between proximity, direct communications and the Internet of Things' Understand the technical and business-related differences between proximity/presence and location' Identify each of the major technologies/solutions for proximity detection, location determination, and direct communications' Evaluation of the market for major applications including public safety, social networking, advertising, the Internet of Things, and general location services Select Companies in Report: ' 3M Company' Alcatel-Lucent' iSIGN' LG' Nokia' Samsung' Qualcomm' Verizon Wireless
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...ReportLinker.com
This new 970-page comprehensive five-country report from Venture Planning Group is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.The $4.5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of and cost-effective automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next five years.
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...ReportLinker.com
This new 900-page five-country market intelligence and technology assessment report from Venture Planning Group will help current suppliers and potential market entrants identify and evaluate emerging opportunities and develop effective strategic responses. The report explores future trends in major European countries (France, Germany, Italy, Spain, UK); provides estimates of the specimen, test and sales volumes, as well as major suppliers sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. However, this evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.
Bradycardia Global Clinical Trials Review, H1, 2013ReportLinker.com
Bradycardia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Bradycardia Global Clinical Trials Review, H1, 2013" provides data on the Bradycardia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bradycardia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bradycardia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013" provides data on the Acid Indigestion / Heartburn/ Pyrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acid Indigestion / Heartburn/ Pyrosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acid Indigestion / Heartburn/ Pyrosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
The biomass market suffered during the economic downturn in the face of low coal prices, logistic barriers and supply issues. 2010 saw more movement in the sector as coal prices are beginning to rise once again making co-firing coal plants with biomass more attractive. Furthermore, the biomass component of a coal-fired plant may be eligible for feed-in tariff or count towards renewable portfolio standards.Most of these plants rely on wood pellets, often transported at great distance, rather than wood chips or other less dense biomass sources. In the wood pellets market, supplies from the US and Canada are cheaper than their European counterparts and thus North America is a major suppli- ers for European biomass plants. CIS countries, Russia, Australia and South Africa have entered as significant suppliers, which if they could ramp up supply, could be serious competitors to the US and Canada. Or in the case of Russia, resolve supply delay issues, could be one of the biggest players in the market.
Inguinal Hernia Global Clinical Trials Review, H1, 2013ReportLinker.com
Inguinal Hernia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Inguinal Hernia Global Clinical Trials Review, H1, 2013" provides data on the Inguinal Hernia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Inguinal Hernia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Inguinal Hernia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Cancer Cachexia Global Clinical Trials Review, H1, 2013ReportLinker.com
Cancer Cachexia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Cancer Cachexia Global Clinical Trials Review, H1, 2013" provides data on the Cancer Cachexia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cancer Cachexia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cancer Cachexia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Pompe Disease Global Clinical Trials Review, H1, 2013ReportLinker.com
Pompe Disease Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Pompe Disease Global Clinical Trials Review, H1, 2013" provides data on the Pompe Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pompe Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pompe Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013ReportLinker.com
Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013" provides data on the Abdominal Aortic Aneurysms clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Abdominal Aortic Aneurysms. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Abdominal Aortic Aneurysms. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Falcon stands out as a top-tier P2P Invoice Discounting platform in India, bridging esteemed blue-chip companies and eager investors. Our goal is to transform the investment landscape in India by establishing a comprehensive destination for borrowers and investors with diverse profiles and needs, all while minimizing risk. What sets Falcon apart is the elimination of intermediaries such as commercial banks and depository institutions, allowing investors to enjoy higher yields.
Global Electric Resistance Welded Pipes IndustryReportLinker.com
This report analyzes the worldwide markets for Electric Resistance Welded Pipes in Thousand Tons by the following Product Segments: Mechanical Steel Tubing, Structural Tubing, Structural Steel Pipes, Pressure Tubing, Standard Pipes, Oil Country Tubular Goods, and Line Pipes. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 181 companies including many key and niche players such as Al Jazeera Steel Products Company SAOG, Arabian Pipes Company, ArcelorMittal SA, ERW Pipes Portfolio of ArcelorMittal ChelPipe, Choo Bee Metal Industries Berhad, EVRAZ North America, JFE Steel Corporation, Maharashtra Seamless Limited, Melewar Industrial Group Berhad, Nippon Steel & Sumitomo Metal Corporation, Northwest Pipe Company, OAO TMK, TMK IPSCO, PT Bakrie Pipe Industries, Salzgitter Mannesmann Line Pipe GmbH, Tata Steel Europe, Techint Group SpA, Tenaris S.A., TenarisSiderca, Ternium S.A., United States Steel Corporation, United Metallurgical Company /OMK, Welspun Corp Ltd., Wheatland Tube Company, and Select Products of Wheatland Tube Company. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
This report analyzes the worldwide markets for Wireless Gaming in US$ Million by the following Product Segments: Messaging Based Wireless Gaming, Browser/Web Based Wireless Gaming, and Downloadable Wireless Gaming. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. The report profiles 90 companies including many key and niche players such as Blockdot, Inc., DeNA Co., Ltd., Electronic Arts, Inc., Gameloft SA,GAMEVIL, GREE International, Inc., Glu Mobile Inc., GigaMedia Limited, HandyGames, I-play, Itsmy
Hyperalgesia Global Clinical Trials Review, H1, 2013ReportLinker.com
Hyperalgesia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Hyperalgesia Global Clinical Trials Review, H1, 2013" provides data on the Hyperalgesia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperalgesia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hyperalgesia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Genital Herpes Global Clinical Trials Review, H1, 2013ReportLinker.com
Genital Herpes Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Genital Herpes Global Clinical Trials Review, H1, 2013" provides data on the Genital Herpes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Genital Herpes. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Genital Herpes. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
The Future of Direct Communications Technologies and Proximity-based Applicat...ReportLinker.com
Overview: There are a number of technologies that may be deployed that all provide the ability for devices to "discover" one another, although over different distances ranging from centimeters (Near Field Communications), to meters (Bluetooth), to 10s of meters (Wi-Fi). They also all provide the ability for the devices to communicate directly with one another without a centralized network. Some of these use direct communication as their primary mode of communication e.g. NFC or RFID. Others are more traditional networks which provide direct communication ability as an adjunct to their primary network functions e.g. LTE-Direct or Wi-Fi Direct. Most of the short-term drivers for proximity-based services will be mobile advertising and social networking, especially friend-finder services or dating services, and gaming. In the longer term, other applications will come into play within the scope of the so called Internet of Things. The challenge and opportunity for network operators will be to develop new user scenarios and even new business models to generate revenues from these services. This research uncovers opportunities that will be both beneficial and disruptive to the existing ecosystem and value chain. This research is must reading for any company that is considering offerings within proximity and direct communications and any company that wants to stay ahead of the crowd in terms of preparation for these disruptive technologies. Target Audience: ' Mobile network operators' Industry verticals of all types' Wireless device manufacturers' Network infrastructure companies' Advertising agencies, brands, and merchants' Social networks, advertising, and content providers' Proximity, location, and direct communications vendors Key Report Benefits: ' Market forecasts for each significant technology/solution approach' Recognize the upcoming role and importance of LTE Direct compared to other solutions' Analysis of the major vendors focused on proximity and direct communications solutions' Understand the relationship between proximity, direct communications and the Internet of Things' Understand the technical and business-related differences between proximity/presence and location' Identify each of the major technologies/solutions for proximity detection, location determination, and direct communications' Evaluation of the market for major applications including public safety, social networking, advertising, the Internet of Things, and general location services Select Companies in Report: ' 3M Company' Alcatel-Lucent' iSIGN' LG' Nokia' Samsung' Qualcomm' Verizon Wireless
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...ReportLinker.com
This new 970-page comprehensive five-country report from Venture Planning Group is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.The $4.5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of and cost-effective automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next five years.
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...ReportLinker.com
This new 900-page five-country market intelligence and technology assessment report from Venture Planning Group will help current suppliers and potential market entrants identify and evaluate emerging opportunities and develop effective strategic responses. The report explores future trends in major European countries (France, Germany, Italy, Spain, UK); provides estimates of the specimen, test and sales volumes, as well as major suppliers sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. However, this evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.
Bradycardia Global Clinical Trials Review, H1, 2013ReportLinker.com
Bradycardia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Bradycardia Global Clinical Trials Review, H1, 2013" provides data on the Bradycardia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bradycardia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bradycardia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013" provides data on the Acid Indigestion / Heartburn/ Pyrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acid Indigestion / Heartburn/ Pyrosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acid Indigestion / Heartburn/ Pyrosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
The biomass market suffered during the economic downturn in the face of low coal prices, logistic barriers and supply issues. 2010 saw more movement in the sector as coal prices are beginning to rise once again making co-firing coal plants with biomass more attractive. Furthermore, the biomass component of a coal-fired plant may be eligible for feed-in tariff or count towards renewable portfolio standards.Most of these plants rely on wood pellets, often transported at great distance, rather than wood chips or other less dense biomass sources. In the wood pellets market, supplies from the US and Canada are cheaper than their European counterparts and thus North America is a major suppli- ers for European biomass plants. CIS countries, Russia, Australia and South Africa have entered as significant suppliers, which if they could ramp up supply, could be serious competitors to the US and Canada. Or in the case of Russia, resolve supply delay issues, could be one of the biggest players in the market.
Inguinal Hernia Global Clinical Trials Review, H1, 2013ReportLinker.com
Inguinal Hernia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Inguinal Hernia Global Clinical Trials Review, H1, 2013" provides data on the Inguinal Hernia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Inguinal Hernia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Inguinal Hernia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Cancer Cachexia Global Clinical Trials Review, H1, 2013ReportLinker.com
Cancer Cachexia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Cancer Cachexia Global Clinical Trials Review, H1, 2013" provides data on the Cancer Cachexia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cancer Cachexia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cancer Cachexia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Pompe Disease Global Clinical Trials Review, H1, 2013ReportLinker.com
Pompe Disease Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Pompe Disease Global Clinical Trials Review, H1, 2013" provides data on the Pompe Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pompe Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pompe Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013ReportLinker.com
Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013" provides data on the Abdominal Aortic Aneurysms clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Abdominal Aortic Aneurysms. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Abdominal Aortic Aneurysms. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Falcon stands out as a top-tier P2P Invoice Discounting platform in India, bridging esteemed blue-chip companies and eager investors. Our goal is to transform the investment landscape in India by establishing a comprehensive destination for borrowers and investors with diverse profiles and needs, all while minimizing risk. What sets Falcon apart is the elimination of intermediaries such as commercial banks and depository institutions, allowing investors to enjoy higher yields.
Kseniya Leshchenko: Shared development support service model as the way to ma...Lviv Startup Club
Kseniya Leshchenko: Shared development support service model as the way to make small projects with small budgets profitable for the company (UA)
Kyiv PMDay 2024 Summer
Website – www.pmday.org
Youtube – https://www.youtube.com/startuplviv
FB – https://www.facebook.com/pmdayconference
Digital Transformation and IT Strategy Toolkit and TemplatesAurelien Domont, MBA
This Digital Transformation and IT Strategy Toolkit was created by ex-McKinsey, Deloitte and BCG Management Consultants, after more than 5,000 hours of work. It is considered the world's best & most comprehensive Digital Transformation and IT Strategy Toolkit. It includes all the Frameworks, Best Practices & Templates required to successfully undertake the Digital Transformation of your organization and define a robust IT Strategy.
Editable Toolkit to help you reuse our content: 700 Powerpoint slides | 35 Excel sheets | 84 minutes of Video training
This PowerPoint presentation is only a small preview of our Toolkits. For more details, visit www.domontconsulting.com
Business Valuation Principles for EntrepreneursBen Wann
This insightful presentation is designed to equip entrepreneurs with the essential knowledge and tools needed to accurately value their businesses. Understanding business valuation is crucial for making informed decisions, whether you're seeking investment, planning to sell, or simply want to gauge your company's worth.
RMD24 | Debunking the non-endemic revenue myth Marvin Vacquier Droop | First ...BBPMedia1
Marvin neemt je in deze presentatie mee in de voordelen van non-endemic advertising op retail media netwerken. Hij brengt ook de uitdagingen in beeld die de markt op dit moment heeft op het gebied van retail media voor niet-leveranciers.
Retail media wordt gezien als het nieuwe advertising-medium en ook mediabureaus richten massaal retail media-afdelingen op. Merken die niet in de betreffende winkel liggen staan ook nog niet in de rij om op de retail media netwerken te adverteren. Marvin belicht de uitdagingen die er zijn om echt aansluiting te vinden op die markt van non-endemic advertising.
RMD24 | Retail media: hoe zet je dit in als je geen AH of Unilever bent? Heid...BBPMedia1
Grote partijen zijn al een tijdje onderweg met retail media. Ondertussen worden in dit domein ook de kansen zichtbaar voor andere spelers in de markt. Maar met die kansen ontstaan ook vragen: Zelf retail media worden of erop adverteren? In welke fase van de funnel past het en hoe integreer je het in een mediaplan? Wat is nu precies het verschil met marketplaces en Programmatic ads? In dit half uur beslechten we de dilemma's en krijg je antwoorden op wanneer het voor jou tijd is om de volgende stap te zetten.
Recruiting in the Digital Age: A Social Media MasterclassLuanWise
In this masterclass, presented at the Global HR Summit on 5th June 2024, Luan Wise explored the essential features of social media platforms that support talent acquisition, including LinkedIn, Facebook, Instagram, X (formerly Twitter) and TikTok.
What is the TDS Return Filing Due Date for FY 2024-25.pdfseoforlegalpillers
It is crucial for the taxpayers to understand about the TDS Return Filing Due Date, so that they can fulfill your TDS obligations efficiently. Taxpayers can avoid penalties by sticking to the deadlines and by accurate filing of TDS. Timely filing of TDS will make sure about the availability of tax credits. You can also seek the professional guidance of experts like Legal Pillers for timely filing of the TDS Return.
[Note: This is a partial preview. To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations]
Sustainability has become an increasingly critical topic as the world recognizes the need to protect our planet and its resources for future generations. Sustainability means meeting our current needs without compromising the ability of future generations to meet theirs. It involves long-term planning and consideration of the consequences of our actions. The goal is to create strategies that ensure the long-term viability of People, Planet, and Profit.
Leading companies such as Nike, Toyota, and Siemens are prioritizing sustainable innovation in their business models, setting an example for others to follow. In this Sustainability training presentation, you will learn key concepts, principles, and practices of sustainability applicable across industries. This training aims to create awareness and educate employees, senior executives, consultants, and other key stakeholders, including investors, policymakers, and supply chain partners, on the importance and implementation of sustainability.
LEARNING OBJECTIVES
1. Develop a comprehensive understanding of the fundamental principles and concepts that form the foundation of sustainability within corporate environments.
2. Explore the sustainability implementation model, focusing on effective measures and reporting strategies to track and communicate sustainability efforts.
3. Identify and define best practices and critical success factors essential for achieving sustainability goals within organizations.
CONTENTS
1. Introduction and Key Concepts of Sustainability
2. Principles and Practices of Sustainability
3. Measures and Reporting in Sustainability
4. Sustainability Implementation & Best Practices
To download the complete presentation, visit: https://www.oeconsulting.com.sg/training-presentations
Affordable Stationery Printing Services in Jaipur | Navpack n PrintNavpack & Print
Looking for professional printing services in Jaipur? Navpack n Print offers high-quality and affordable stationery printing for all your business needs. Stand out with custom stationery designs and fast turnaround times. Contact us today for a quote!
1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Soft drinks in Thailand to 2013
Published on May 2009
Report Summary
Introduction
This databook is a detailed information resource covering all the key data points on Soft drinks in Thailand. It includes comprehensive
value volume segmentation and market share data. The databook supplies actual data to 2008 and full forecasts to 2013.
Scope
*Contains information on 7 categories: Carbonates, Bottled water, Juices, RTD tea & coffee, Functional drinks, Smoothies and
Concentrates
*Provides market value, volume, expenditure and consumption data by market, category and segment
*Includes company and brand share data by categories
Highlights
The market for Soft drinks in Thailand increased between 2003-2008, growing at an average annual rate of 4.6%.
The leading company in the market in 2008 was Pepsico, Inc. The second-largest player was Coca-Cola Company, The with Nestle
S.A. in third place.
Reasons to Purchase
*Discover the major quantitative trends affecting the Soft drinks markets
*Understand consumers' consumption and expenditure patterns
*Understand the future direction of the market with reliable historical data and full five year forecasting
Table of Content
TABLE OF CONTENT
Chapter 1 EXECUTIVE SUMMARY 2
Soft drinks in Thailand to 2013 Page 1/9
2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Summary Market Level - Soft drinks 2
Summary category level - Functional drinks 3
Summary category level - Bottled water 4
Summary category level - Carbonates 5
Summary category level - RTD tea & coffee 6
Summary category level - Juices 7
Chapter 2 INTRODUCTION 8
What is this report about' 8
How to use this report 8
Market Definition 9
Chapter 3 MARKET OVERVIEW 23
Value Analysis, 2003-2008 23
Value Analysis, 2008-2013 24
Value Analysis, US$ 2003-2008 27
Value Analysis, US$ 2008-2013 28
Volume Analysis, 2003-2008 30
Volume Analysis, 2008-2013 31
Company and Brand Share Analysis 33
Distribution Analysis 40
Expenditure & consumption per capita 42
Chapter 4 LEADING COMPANY PROFILES 48
PepsiCo, Inc. 48
The Coca-Cola Company 51
Chapter 5 CATEGORY ANALYSIS - FUNCTIONAL DRINKS 54
Value Analysis, 2003-2008 54
Value Analysis, 2008-2013 55
Value Analysis, US$ 2003-2008 57
Value Analysis, US$ 2008-2013 57
Volume Analysis, 2003-2008 59
Volume Analysis, 2008-2013 60
Company and Brand Share Analysis 63
Distribution Analysis 66
Expenditure & consumption per capita 68
Chapter 6 CATEGORY ANALYSIS - BOTTLED WATER 71
Value Analysis, 2003-2008 71
Value Analysis, 2008-2013 72
Value Analysis, US$ 2003-2008 74
Value Analysis, US$ 2008-2013 74
Volume Analysis, 2003-2008 76
Volume Analysis, 2008-2013 77
Company and Brand Share Analysis 80
Distribution Analysis 83
Expenditure & consumption per capita 85
Chapter 7 CATEGORY ANALYSIS - CARBONATES 88
Value Analysis, 2003-2008 88
Value Analysis, 2008-2013 89
Value Analysis, US$ 2003-2008 91
Value Analysis, US$ 2008-2013 92
Volume Analysis, 2003-2008 94
Volume Analysis, 2008-2013 95
Soft drinks in Thailand to 2013 Page 2/9
3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Company and Brand Share Analysis 97
Distribution Analysis 100
Expenditure & consumption per capita 102
Chapter 8 CATEGORY ANALYSIS - RTD TEA & COFFEE 106
Value Analysis, 2003-2008 106
Value Analysis, 2008-2013 107
Value Analysis, US$ 2003-2008 109
Value Analysis, US$ 2008-2013 109
Volume Analysis, 2003-2008 111
Volume Analysis, 2008-2013 112
Company and Brand Share Analysis 114
Distribution Analysis 118
Expenditure & consumption per capita 120
Chapter 9 CATEGORY ANALYSIS - JUICES 123
Value Analysis, 2003-2008 123
Value Analysis, 2008-2013 124
Value Analysis, US$ 2003-2008 126
Value Analysis, US$ 2008-2013 127
Volume Analysis, 2003-2008 129
Volume Analysis, 2008-2013 130
Company and Brand Share Analysis 132
Distribution Analysis 137
Expenditure & consumption per capita 139
Chapter 10 NEW PRODUCT DEVELOPMENT 145
Product launches over time 145
Recent product launches 148
Chapter 11 THAILAND SOCIOECONOMIC PROFILE 149
Country Overview 149
Key Facts 150
Political Overview 151
Thailand Economic Overview 152
Chapter 12 THAILAND MACROECONOMIC PROFILE 153
Macroeconomic Indicators 153
Chapter 13 RESEARCH METHODOLOGY 158
Methodology overview 158
Secondary research 159
Market modeling 160
Primary research 161
Data finalization 162
Ongoing research 162
Chapter 14 APPENDIX 163
Future readings 163
How to contact experts in your industry 163
Disclaimer 163
LIST OF FIGURES
Soft drinks in Thailand to 2013 Page 3/9
4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Figure 1: Thailand soft drinks value and value forecast, 2003-2013 (THB m, nominal prices) 26
Figure 2: Thailand soft drinks category growth comparison, by value, 2003-2013 29
Figure 3: Thailand soft drinks volume and volume forecast, 2003-2013 (Liters m) 32
Figure 4: Thailand soft drinks category growth comparison, by volume, 2003-2013 32
Figure 5: Thailand soft drinks company share, by volume, 2007-2008 (%) 37
Figure 6: Thailand soft drinks distribution channels, by volume, 2007-2008 (%) 41
Figure 7: Thailand functional drinks value and value forecast, 2003-2013 (THB m, nominal prices) 56
Figure 8: Thailand functional drinks category growth comparison, by value, 2003-2013 58
Figure 9: Thailand functional drinks volume and volume forecast, 2003-2013 (Liters m) 61
Figure 10: Thailand functional drinks category growth comparison, by volume, 2003-2013 62
Figure 11: Thailand functional drinks company share, by volume, 2007-2008 (%) 64
Figure 12: Thailand functional drinks distribution channels, by volume, 2007-2008 (%) 67
Figure 13: Thailand bottled water value and value forecast, 2003-2013 (THB m, nominal prices) 73
Figure 14: Thailand bottled water category growth comparison, by value, 2003-2013 75
Figure 15: Thailand bottled water volume and volume forecast, 2003-2013 (Liters m) 78
Figure 16: Thailand bottled water category growth comparison, by volume, 2003-2013 79
Figure 17: Thailand bottled water company share, by volume, 2007-2008 (%) 81
Figure 18: Thailand bottled water distribution channels, by volume, 2007-2008 (%) 84
Figure 19: Thailand carbonates value and value forecast, 2003-2013 (THB m, nominal prices) 90
Figure 20: Thailand carbonates category growth comparison, by value, 2003-2013 93
Figure 21: Thailand carbonates volume and volume forecast, 2003-2013 (Liters m) 96
Figure 22: Thailand carbonates category growth comparison, by volume, 2003-2013 96
Figure 23: Thailand carbonates company share, by volume, 2007-2008 (%) 98
Figure 24: Thailand carbonates distribution channels, by volume, 2007-2008 (%) 101
Figure 25: Thailand RTD tea & coffee value and value forecast, 2003-2013 (THB m, nominal prices) 108
Figure 26: Thailand RTD tea & coffee category growth comparison, by value, 2003-2013 110
Figure 27: Thailand RTD tea & coffee volume and volume forecast, 2003-2013 (Liters m) 113
Figure 28: Thailand RTD tea & coffee category growth comparison, by volume, 2003-2013 113
Figure 29: Thailand RTD tea & coffee company share, by volume, 2007-2008 (%) 116
Figure 30: Thailand RTD tea & coffee distribution channels, by volume, 2007-2008 (%) 119
Figure 31: Thailand juices value and value forecast, 2003-2013 (THB m, nominal prices) 125
Figure 32: Thailand juices category growth comparison, by value, 2003-2013 128
Figure 33: Thailand juices volume and volume forecast, 2003-2013 (Liters m) 131
Figure 34: Thailand juices category growth comparison, by volume, 2003-2013 131
Figure 35: Thailand juices company share, by volume, 2007-2008 (%) 134
Figure 36: Thailand juices distribution channels, by volume, 2007-2008 (%) 138
Figure 37: Map of Thailand 150
Figure 38: Annual data review process 159
LIST OF TABLES
Table 1: Soft drinks category definitions 10
Table 2: Soft drinks distribution channels 11
Table 3: Thailand soft drinks value, 2003-2008 (THB m, nominal prices) 23
Table 4: Thailand soft drinks value forecast, 2008-2013 (THB m, nominal prices) 25
Table 5: Thailand soft drinks value, 2003-2008 (US$ m nominal prices) 27
Table 6: Thailand soft drinks value forecast, 2008-2013 (US$ m nominal prices) 28
Soft drinks in Thailand to 2013 Page 4/9
5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Table 7: Thailand soft drinks volume, 2003-2008 (Liters m) 30
Table 8: Thailand soft drinks volume forecast, 2008-2013 (Liters m) 31
Table 9: Thailand soft drinks brand share, by volume, 2007-2008 (%) 33
Table 10: Thailand soft drinks volume, by brand 2007-2008 (Liters m) 35
Table 11: Thailand soft drinks company share by volume, 2007-2008 (%) 38
Table 12: Thailand soft drinks volume, by company, 2007-2008 (Liters m) 39
Table 13: Thailand soft drinks distribution channels, by volume, 2007-2008 (%) 40
Table 14: Thailand soft drinks volume, by distribution channel, 2007-2008 (Liters m) 40
Table 15: Thailand soft drinks expenditure per capita, 2003-2008 (THB, nominal prices) 42
Table 16: Thailand soft drinks forecast expenditure per capita, 2008-2013 (THB, nominal prices) 43
Table 17: Thailand soft drinks expenditure per capita, 2003-2008 (US$ nominal prices) 44
Table 18: Thailand soft drinks forecast expenditure per capita, 2008-2013 (US$ nominal prices) 45
Table 19: Thailand soft drinks consumption per capita, 2003-2008 (Liters) 46
Table 20: Thailand soft drinks forecast consumption per capita, 2008-2013 (Liters) 47
Table 21: PepsiCo, Inc. Key Facts 48
Table 22: The Coca-Cola Company Key Facts 51
Table 23: Thailand functional drinks value, 2003-2008 (THB m, nominal prices) 54
Table 24: Thailand functional drinks value forecast, 2008-2013 (THB m, nominal prices) 55
Table 25: Thailand functional drinks value, 2003-2008 (US$ m nominal prices) 57
Table 26: Thailand functional drinks value forecast, 2008-2013 (US$ m nominal prices) 57
Table 27: Thailand functional drinks volume, 2003-2008 (Liters m) 59
Table 28: Thailand functional drinks volume forecast, 2008-2013 (Liters m) 60
Table 29: Thailand functional drinks brand share, by volume, 2007-2008 (%) 63
Table 30: Thailand functional drinks volume, by brand 2007-2008 (Liters m) 63
Table 31: Thailand functional drinks company share by volume, 2007-2008 (%) 65
Table 32: Thailand functional drinks volume, by company, 2007-2008 (Liters m) 65
Table 33: Thailand functional drinks distribution channels, by volume, 2007-2008 (%) 66
Table 34: Thailand functional drinks volume, by distribution channel, 2007-2008 (Liters m) 66
Table 35: Thailand functional drinks expenditure per capita, 2003-2008 (THB, nominal prices) 68
Table 36: Thailand functional drinks forecast expenditure per capita, 2008-2013 (THB, nominal prices) 68
Table 37: Thailand functional drinks expenditure per capita, 2003-2008 (US$ nominal prices) 69
Table 38: Thailand functional drinks forecast expenditure per capita, 2008-2013 (US$ nominal prices) 69
Table 39: Thailand functional drinks consumption per capita, 2003-2008 (Liters) 70
Table 40: Thailand functional drinks forecast consumption per capita, 2008-2013 (Liters) 70
Table 41: Thailand bottled water value, 2003-2008 (THB m, nominal prices) 71
Table 42: Thailand bottled water value forecast, 2008-2013 (THB m, nominal prices) 72
Table 43: Thailand bottled water value, 2003-2008 (US$ m nominal prices) 74
Table 44: Thailand bottled water value forecast, 2008-2013 (US$ m nominal prices) 74
Table 45: Thailand bottled water volume, 2003-2008 (Liters m) 76
Table 46: Thailand bottled water volume forecast, 2008-2013 (Liters m) 77
Table 47: Thailand bottled water brand share, by volume, 2007-2008 (%) 80
Table 48: Thailand bottled water volume, by brand 2007-2008 (Liters m) 80
Table 49: Thailand bottled water company share by volume, 2007-2008 (%) 82
Table 50: Thailand bottled water volume, by company, 2007-2008 (Liters m) 82
Table 51: Thailand bottled water distribution channels, by volume, 2007-2008 (%) 83
Table 52: Thailand bottled water volume, by distribution channel, 2007-2008 (Liters m) 83
Table 53: Thailand bottled water expenditure per capita, 2003-2008 (THB, nominal prices) 85
Table 54: Thailand bottled water forecast expenditure per capita, 2008-2013 (THB, nominal prices) 85
Table 55: Thailand bottled water expenditure per capita, 2003-2008 (US$ nominal prices) 86
Table 56: Thailand bottled water forecast expenditure per capita, 2008-2013 (US$ nominal prices) 86
Soft drinks in Thailand to 2013 Page 5/9
6. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Table 57: Thailand bottled water consumption per capita, 2003-2008 (Liters) 87
Table 58: Thailand bottled water forecast consumption per capita, 2008-2013 (Liters) 87
Table 59: Thailand carbonates value, 2003-2008 (THB m, nominal prices) 88
Table 60: Thailand carbonates value forecast, 2008-2013 (THB m, nominal prices) 89
Table 61: Thailand carbonates value, 2003-2008 (US$ m nominal prices) 91
Table 62: Thailand carbonates value forecast, 2008-2013 (US$ m nominal prices) 92
Table 63: Thailand carbonates volume, 2003-2008 (Liters m) 94
Table 64: Thailand carbonates volume forecast, 2008-2013 (Liters m) 95
Table 65: Thailand carbonates brand share, by volume, 2007-2008 (%) 97
Table 66: Thailand carbonates volume, by brand 2007-2008 (Liters m) 97
Table 67: Thailand carbonates company share by volume, 2007-2008 (%) 99
Table 68: Thailand carbonates volume, by company, 2007-2008 (Liters m) 99
Table 69: Thailand carbonates distribution channels, by volume, 2007-2008 (%) 100
Table 70: Thailand carbonates volume, by distribution channel, 2007-2008 (Liters m) 100
Table 71: Thailand carbonates expenditure per capita, 2003-2008 (THB, nominal prices) 102
Table 72: Thailand carbonates forecast expenditure per capita, 2008-2013 (THB, nominal prices) 103
Table 73: Thailand carbonates expenditure per capita, 2003-2008 (US$ nominal prices) 103
Table 74: Thailand carbonates forecast expenditure per capita, 2008-2013 (US$ nominal prices) 104
Table 75: Thailand carbonates consumption per capita, 2003-2008 (Liters) 104
Table 76: Thailand carbonates forecast consumption per capita, 2008-2013 (Liters) 105
Table 77: Thailand RTD tea & coffee value, 2003-2008 (THB m, nominal prices) 106
Table 78: Thailand RTD tea & coffee value forecast, 2008-2013 (THB m, nominal prices) 107
Table 79: Thailand RTD tea & coffee value, 2003-2008 (US$ m nominal prices) 109
Table 80: Thailand RTD tea & coffee value forecast, 2008-2013 (US$ m nominal prices) 109
Table 81: Thailand RTD tea & coffee volume, 2003-2008 (Liters m) 111
Table 82: Thailand RTD tea & coffee volume forecast, 2008-2013 (Liters m) 112
Table 83: Thailand RTD tea & coffee brand share, by volume, 2007-2008 (%) 114
Table 84: Thailand RTD tea & coffee volume, by brand 2007-2008 (Liters m) 115
Table 85: Thailand RTD tea & coffee company share by volume, 2007-2008 (%) 117
Table 86: Thailand RTD tea & coffee volume, by company, 2007-2008 (Liters m) 117
Table 87: Thailand RTD tea & coffee distribution channels, by volume, 2007-2008 (%) 118
Table 88: Thailand RTD tea & coffee volume, by distribution channel, 2007-2008 (Liters m) 118
Table 89: Thailand RTD tea & coffee expenditure per capita, 2003-2008 (THB, nominal prices) 120
Table 90: Thailand RTD tea & coffee forecast expenditure per capita, 2008-2013 (THB, nominal prices) 120
Table 91: Thailand RTD tea & coffee expenditure per capita, 2003-2008 (US$ nominal prices) 121
Table 92: Thailand RTD tea & coffee forecast expenditure per capita, 2008-2013 (US$ nominal prices) 121
Table 93: Thailand RTD tea & coffee consumption per capita, 2003-2008 (Liters) 122
Table 94: Thailand RTD tea & coffee forecast consumption per capita, 2008-2013 (Liters) 122
Table 95: Thailand juices value, 2003-2008 (THB m, nominal prices) 123
Table 96: Thailand juices value forecast, 2008-2013 (THB m, nominal prices) 124
Table 97: Thailand juices value, 2003-2008 (US$ m nominal prices) 126
Table 98: Thailand juices value forecast, 2008-2013 (US$ m nominal prices) 127
Table 99: Thailand juices volume, 2003-2008 (Liters m) 129
Table 100: Thailand juices volume forecast, 2008-2013 (Liters m) 130
Table 101: Thailand juices brand share, by volume, 2007-2008 (%) 132
Table 102: Thailand juices volume, by brand 2007-2008 (Liters m) 133
Table 103: Thailand juices company share by volume, 2007-2008 (%) 135
Table 104: Thailand juices volume, by company, 2007-2008 (Liters m) 136
Table 105: Thailand juices distribution channels, by volume, 2007-2008 (%) 137
Table 106: Thailand juices volume, by distribution channel, 2007-2008 (Liters m) 137
Soft drinks in Thailand to 2013 Page 6/9
7. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Table 107: Thailand juices expenditure per capita, 2003-2008 (THB, nominal prices) 139
Table 108: Thailand juices forecast expenditure per capita, 2008-2013 (THB, nominal prices) 140
Table 109: Thailand juices expenditure per capita, 2003-2008 (US$ nominal prices) 141
Table 110: Thailand juices forecast expenditure per capita, 2008-2013 (US$ nominal prices) 142
Table 111: Thailand juices consumption per capita, 2003-2008 (Liters) 143
Table 112: Thailand juices forecast consumption per capita, 2008-2013 (Liters) 144
Table 113: Thailand soft drinks new product launches reports, by company (Top 5 companies), 2008 145
Table 114: Thailand soft drinks new product launches SKUs, by company (Top 5 companies), 2008 145
Table 115: Thailand soft drinks new product launches (reports), by flavor and fragrances (Top 10 flavors), 2008 146
Table 116: Thailand soft drinks new product launches (reports), by Ingredients (Top 10 Ingredients), 2008 146
Table 117: Thailand soft drinks new product launches (reports), by Package tags or Claims (Top 10 claims), 2008 147
Table 118: Thailand soft drinks new product launches (reports) - Recent 5 launches (2008) 148
Table 119: Thailand Key Facts 150
Table 120: Thailand population, by age group, 2003-2008 (millions) 153
Table 121: Thailand population forecast, by age group, 2008-2013 (millions) 154
Table 122: Thailand population, by gender, 2003-2008 (millions) 154
Table 123: Thailand population forecast, by gender, 2008-2013 (millions) 155
Table 124: Thailand nominal GDP, 2003-2008 (BHT bn, 2000 prices) 155
Table 125: Thailand nominal GDP forecast, 2008-2013 (BHT bn, 2000 prices) 155
Table 126: Thailand real GDP, 2003-2008 (BHT bn, nominal prices) 156
Table 127: Thailand real GDP forecast, 2008-2013 (BHT bn, nominal prices) 156
Table 128: Thailand real GDP, 2003-2008 (US$ bn, 2000 prices) 156
Table 129: Thailand real GDP forecast, 2008-2013 (US$ bn, 2000 prices) 157
Table 130: Thailand consumer price index, 2003-2008 (2000=100) 157
Table 131: Thailand consumer price index, 2008-2013 (2000=100) 157
Soft drinks in Thailand to 2013 Page 7/9
8. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Soft drinks in Thailand to 2013
Product Formats
Please select the product formats and the quantity you require.
Digital Copy--USD 495.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Soft drinks in Thailand to 2013 Page 8/9
9. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Soft drinks in Thailand to 2013 Page 9/9